9 Meters Biopharma, Inc. (NMTRQ)

9 Meters Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Feb 12, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	0	16	250	175	20	60
Market Cap Growth	10228.57%	-93.48%	43.21%	774.01%	-66.81%	-
Enterprise Value	-	19	197	164	15	57
Last Close Price	0.00	1.26	19.57	17.18	11.14	46.20
PB Ratio	0.00	6.80	6.01	5.44	-2.08	-16.46
P/TBV Ratio	-	6.80	6.01	5.44	-	-
Debt / Equity Ratio	-0.82	8.22	0.00	0.01	-0.34	-1.42
Net Debt / Equity Ratio	0.28	2.95	-1.13	-1.17	0.14	0.14
Net Debt / EBITDA Ratio	0.04	-0.17	1.50	1.82	0.06	0.03
Net Debt / FCF Ratio	0.05	-0.19	1.59	1.94	0.08	0.04
Quick Ratio	0.45	0.41	5.56	5.53	0.31	0.57
Current Ratio	0.59	1.08	5.91	5.68	0.35	0.63
Return on Equity (ROE)	-375.64%	-198.92%	-99.75%	-545.95%	-	-
Return on Assets (ROA)	-111.78%	-63.03%	-43.74%	-58.07%	-255.11%	-314.09%
Return on Capital Employed (ROCE)	693.40%	-1713.60%	-74.90%	-63.90%	249.50%	498.10%
Earnings Yield	-3200769.92%	-268.11%	-14.70%	-35.20%	-135.31%	-40.12%
FCF Yield	-	-228.17%	-11.79%	-11.11%	-89.94%	-25.21%
Buyback Yield / Dilution	-3.01%	-6.58%	-130.12%	-216.97%	-34.59%	-108.29%

Updated May 15, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.